Tower Research Capital LLC (Trc) Revelation Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.18 - $431.55 $56 - $134,643	-312 Reduced 3.55%	8,472 $2,000
Q3 2022 Nov 10, 2022	BUY	$0.09 - $1438.5 $265 - $4.25 Million	2,954 Added 50.67%	8,784 $2,000
Q2 2022 Aug 15, 2022	BUY	$448.98 - $1344.0 $1.05 Million - $3.13 Million	2,328 Added 66.48%	5,830 $6,000
Q1 2022 May 12, 2022	BUY	$971.04 - $11077.5 $3.4 Million - $38.8 Million	3,502 New	3,502 $4,000

Ticker REVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,525,800
Market Cap $17.4M
Description
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal conge...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.